Schaefer Thomas J. has filed 5 insider transactions across 1 company since February 2024.
Most recent transaction: a grant/award of 12500 shares of Arcadia Biosciences, Inc. ($RKDA) on May 09, 2025.
Activity breakdown: 3 open-market purchases and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 9, 2025 | Arcadia Biosciences, Inc. | $RKDA | Schaefer Thomas J. | Chief Executive Officer | A | Stock Option (Right to Buy) | 12500 | $0.00 | 37,975.0000 | 1,367,040 | 49.07% | 0.91% |
| Feb. 3, 2025 | Arcadia Biosciences, Inc. | $RKDA | Schaefer Thomas J. | Chief Executive Officer | P | Common Stock | 700 | $2.49 | 2,819.0000 | 0 | 33.03% | 0.00% |
| Aug. 19, 2024 | Arcadia Biosciences, Inc. | $RKDA | Schaefer Thomas J. | Chief Executive Officer | A | Stock Option (Right to Buy) | 20000 | $0.00 | 25,475.0000 | 0 | 365.30% | 0.00% |
| Aug. 1, 2024 | Arcadia Biosciences, Inc. | $RKDA | Schaefer Thomas J. | Chief Executive Officer | P | Common Stock | 700 | $2.06 | 2,119.0000 | 0 | 49.33% | 0.00% |
| Feb. 1, 2024 | Arcadia Biosciences, Inc. | $RKDA | Schaefer Thomas J. | Chief Financial Officer | P | Common Stock | 700 | $2.06 | 1,419.0000 | 0 | 97.36% | 0.00% |